Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

It must be aggressive enough to fight infections and cancer, yet restrained enough to avoid attacking the body's own tissues.

How do regulators address concerns in the court of evidentiary decision making -- and of public opinion -- surrounding ...

Learn more about whether BioMarin Pharmaceutical Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...

Oscar-winning filmmaker Guillermo del Toro was honored with SFFilm's Sloan Science in Cinema Prize for "Frankenstein," an ...

Chinechendo Eze is a Nigerian microbiologist and biotechnologist with research focuses on how to genetically engineer crops to enhance growth and resilience. She is a doctoral student and a graduate ...

In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...

A new early stage trial suggests a single CRISPR based gene edit could permanently cut dangerous cholesterol. In 15 adults ...

Scientists at Georgia State University have used CRISPR gene editing to restore an ancient enzyme humans lost millions of years ago potentially reversing the buildup of uric acid that causes gout.

As we approach the anticipated artificial intelligence singularity and the strain builds, showing the fault lines in our systems, different aspects emerge and begin to converge.

The N-glycans attached to the Fc region of immunoglobulin G (IgG) contain combinations of core fucose, bisecting GlcNAc, galactose, and sialic acid; variations in these monosaccharides - regulated ...